EZH2 and cancer: More recently, EZH2 inhibition was found to facilitate natural killer (NK) cell-mediated cancer cell eradication through re-expression of NK cell ligands in HCC cells, suggesting the use of EZH2 inhibitors in rendering HCC cells more susceptible to NK-mediated cytotoxicity [63].